The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.21

Today's change-0.04 -3.21%
Updated May 31 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.21

Today's change-0.04 -3.21%
Updated May 31 4:00 PM -4GMT. Delayed by at least 15 minutes.

Sharp drop following new 100-day high

Neptune Technologies & Bioressources Inc closed sharply lower Tuesday, dropping (U.S.)$0.04 or 3.21% to (U.S.)$1.21 after setting a new 100-day high. Over the last five days, shares have gained 9.01% and 13.08% year to date. Shares have underperformed the S&P 500 by 6.43% during the last year.

Key company metrics

  • Open(U.S.) $1.28
  • Previous close(U.S.) $1.25
  • High(U.S.) $1.29
  • Low(U.S.) $1.21
  • Bid / Ask(U.S.) $0.00 / (U.S.) $1.29
  • YTD % change+13.08%
  • Volume99,004
  • Average volume (10-day)60,596
  • Average volume (1-month)63,094
  • Average volume (3-month)82,078
  • 52-week range(U.S.) $0.86 to (U.S.) $1.52
  • Beta0.60
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward31.25×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.23
Updated May 31 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-127.12%

Although this company's net profit margin is negative, it is above the industry average and implies that Neptune Technologies & Bioressources Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.15%Sector:Industry:

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedNov 30, 201511/30/2015Aug 31, 201508/31/2015May 31, 201505/31/2015Feb 28, 201502/28/2015
Revenue6434
Total other revenue--------
Total revenue6434
Gross profit21-1-5
Total cost of revenue4449
Total operating expense98915
Selling / general / administrative3344
Research & development2223
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total-1-100
Operating income-3-3-6-11
Interest income (expense), net non-operating000--
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-3-5-11
Income after tax-3-3-5-11
Income tax, total0000
Net income-2-2-4-9
Total adjustments to net income--------
Net income before extra. items-2-2-4-9
Minority interest1111
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-2-4-9
Inc. avail. to common incl. extra. items-2-2-4-9
Diluted net income-2-2-4-9
Dilution adjustment------0
Diluted weighted average shares75757575
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.02-0.06-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.02-0.06-0.12
R